UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 845

Sortiert nach

A [1,5] sigmatropic hydrogen shift induced by high vibrational overtone excitation: the isomerization of 2-methylcyclopentadiene

Journal of physical chemistry (1952), 1983-06, Vol.87 (12), p.2209-2213

1983

Volltextzugriff (PDF)

1 - Laser Isotope Separation

Chemical and Biochemical Applications of Lasers V3, 1977, p.1-165

1977

Volltextzugriff (PDF)

1 - Laser Sources

Chemical and Biochemical Applications of Lasers V1, 1974, p.1-27

1974

Volltextzugriff (PDF)

100,000 Genomes Pilot on Rare-Disease Diagnosis in Health Care — Preliminary Report

The New England journal of medicine, 2021-11, Vol.385 (20), p.1868-1880

2021

Volltextzugriff (PDF)

(1338) - Perception vs. Reality: Reported and Objective Measures of Physical Activity in Children with Hypertrophic Cardiomyopathy (HCM)

The Journal of heart and lung transplantation, 2024-04, Vol.43 (4), p.S617-S617

2024

Volltextzugriff (PDF)

2015 SPCTPD/ACC/AAP/AHA Training Guidelines for Pediatric Cardiology Fellowship Programs (Revision of the 2005 Training Guidelines for Pediatric Cardiology Fellowship Programs)

Circulation (New York, N.Y.), 2015-08, Vol.132 (6), p.e41-e42

2015

Volltextzugriff (PDF)

234O Maintenance olaparib for patients (pts) with newly diagnosed, advanced ovarian cancer (OC) and a BRCA mutation (BRCAm): 5-year (y) follow-up (f/u) from SOLO1

Annals of oncology, 2020-11, Vol.31, p.S1334-S1334

2020

Volltextzugriff (PDF)

487 ARTISTRY-7: a phase 3, multicenter study of nemvaleukin alfa in combination with pembrolizumab versus chemotherapy in patients with platinum-resistant epithelial ovarian, fallopian tube, or primary peritoneal cancer (GOG-3063; ENGOT-OV68)

International journal of gynecological cancer, 2023-09, Vol.33 (Suppl 3), p.A416-A416

2023

Volltextzugriff (PDF)

517O Overall survival (OS) at 7-year (y) follow-up (f/u) in patients (pts) with newly diagnosed advanced ovarian cancer (OC) and a BRCA mutation (BRCAm) who received maintenance olaparib in the SOLO1/GOG-3004 trial

Annals of oncology, 2022-09, Vol.33, p.S779

2022

Volltextzugriff (PDF)

811MO Maintenance olaparib for patients (pts) with newly diagnosed, advanced ovarian cancer (OC) and a BRCA mutation (BRCAm): 5-year (y) follow-up (f/u) from SOLO1

Annals of oncology, 2020-09, Vol.31, p.S613-S613

2020

Volltextzugriff (PDF)

818P Veliparib with carboplatin and paclitaxel in frontline high-grade serous ovarian cancer (HGSOC): Efficacy and safety of paclitaxel weekly and every 3 weeks in the VELIA study

Annals of oncology, 2020-09, Vol.31, p.S618-S618

2020

Volltextzugriff (PDF)

995PD - Time to second progression (PFS2) and second subsequent therapy (TSST) for patients (pts) with newly diagnosed, advanced ovarian cancer (OC) and a BRCA mutation (BRCAm) treated with maintenance (mt) olaparib (ola): Phase III SOLO1 trial

Annals of oncology, 2019-10, Vol.30, p.v405-v405

2019

Volltextzugriff (PDF)

995PDTime to second progression (PFS2) and second subsequent therapy (TSST) for patients (pts) with newly diagnosed, advanced ovarian cancer (OC) and a BRCA mutation (BRCAm) treated with maintenance (mt) olaparib (ola): Phase III SOLO1 trial

Annals of oncology, 2019-10, Vol.30 (Supplement_5)

2019

Volltextzugriff (PDF)

996PD - Patient-centred outcomes with maintenance olaparib in newly diagnosed patients with advanced ovarian cancer (OC) and a BRCA mutation (BRCAm) in the phase III SOLO1 trial to support the clinical benefit of prolongation of progression-free survival (PFS)

Annals of oncology, 2019-10, Vol.30, p.v405-v406

2019

Volltextzugriff (PDF)

996PDPatient-centred outcomes with maintenance olaparib in newly diagnosed patients with advanced ovarian cancer (OC) and a BRCA mutation (BRCAm) in the phase III SOLO1 trial to support the clinical benefit of prolongation of progression-free survival (PFS)

Annals of oncology, 2019-10, Vol.30 (Supplement_5)

2019

Volltextzugriff (PDF)

The Abdominal Trauma Index—A Critical Reassessment and Validation

The journal of trauma, 1990-11, Vol.30 (11), p.1340-1344

1990

Volltextzugriff (PDF)

Absolute yields of carbon monoxide, carbon dioxide, and formaldehyde from the reaction methylene(~X3B1) + oxygen by IR diode laser flash kinetic spectroscopy

Journal of physical chemistry (1952), 1994-01, Vol.98 (1), p.174-183

1994

Volltextzugriff (PDF)

Absolute yields of CO, CO2, and H2CO from the reaction CH2(X3B1) + O2 by IR diode laser flash kinetic spectroscopy

Journal of physical chemistry (1952), 1994, Vol.98 (1), p.174-183

1994

Volltextzugriff (PDF)

Absorption of fortification iron in bread

The American journal of clinical nutrition, 1973-08, Vol.26 (8), p.861-872

1973

Volltextzugriff (PDF)

Abstract 2862: The balance of divergent IRE1α signaling regulates pancreatic neuroendocrine tumor growth

Cancer research (Chicago, Ill.), 2016-07, Vol.76 (14_Supplement), p.2862-2862

2016

Volltextzugriff (PDF)

ACCF/ACR/AIUM/ASE/ASN/ICAVL/SCAI/SCCT/SIR/SVM/SVS 2012 Appropriate Use Criteria for Peripheral Vascular Ultrasound and Physiological Testing Part I: Arterial Ultrasound and Physiological Testing: A Report of the American College of Cardiology Foundation Appropriate Use Criteria Task Force, American College of Radiology, American Institute of Ultrasound in Medicine, American Society of Echocardiography, American Society of Nephrology, Intersocietal Commission for the Accreditation of Vascular Laboratories, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Computed Tomography, Society for Interventional Radiology, Society for Vascular Medicine, and Society

Journal of the American College of Cardiology, 2012-06, Vol.60 (3), p.242-276

2012

Volltextzugriff (PDF)

ACCF/ACR/AIUM/ASE/ASN/ICAVL/SCAI/SCCT/SIR/SVM/SVS 2012 Appropriate Use Criteria for Peripheral Vascular Ultrasound and Physiological Testing Part I: Arterial Ultrasound and Physiological Testing

Journal of the American College of Cardiology, 2012-07, Vol.60 (3), p.242-276

2012

Volltextzugriff (PDF)

ACCF/ACR/AIUM/ASE/ASN/ICAVL/SCAI/SCCT/SIR/SVM/SVS 2012 appropriate use criteria for peripheral vascular ultrasound and physiological testing part I: arterial ultrasound and physiological testing: a report of the American College of Cardiology Foundation Appropriate Use Criteria Task Force, American College of Radiology, American Institute of Ultrasound in Medicine, American Society of Echocardiography, American Society of Nephrology, Intersocietal Commission for the Accreditation of Vascular Lab

Journal of vascular surgery, 2012-07, Vol.56 (1), p.e17-e51

2012

Volltextzugriff (PDF)

ACCF/ACR/AIUM/ASE/ASN/ICAVL/SCAI/SCCT/SIR/SVM/SVS/SVU [corrected] 2012 appropriate use criteria for peripheral vascular ultrasound and physiological testing part I: arterial ultrasound and physiological testing: a report of the American College of Cardiology Foundation appropriate use criteria task force, American College of Radiology, American Institute of Ultrasound in Medicine, American Society of Echocardiography, American Society of Nephrology, Intersocietal Commission for the Accreditation

Journal of the American College of Cardiology, 2012-07, Vol.60 (3), p.242-276

2012

Volltextzugriff (PDF)

Activation and cleaning of oxide surfaces by a cw CO 2 laser

Surface science letters, 1984, Vol.136 (1), p.L19-L24

1984

Volltextzugriff (PDF)

1 – 25 von 845

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(744)
Mit Volltextzugriff
(730)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Englisch
(841)
Japanisch
(159)
Deutsch
(1)
Russisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(530)
Life Sciences & Biomedicine
(309)
Humans
(221)
Physical Sciences
(201)
Chemistry
(180)
Physics
(128)
Female
(125)
Male
(105)
Chemistry, Physical
(101)
Physics, Atomic, Molecular & Chemical
(84)
Adult
(75)
Biological And Medical Sciences
(75)
Middle Aged
(67)
Exact Sciences And Technology
(65)
Biochemistry & Molecular Biology
(55)
Medical Sciences
(51)
Atomic And Molecular Physics
(49)
Aged
(47)
Animals
(46)
Biochemical Engineering
(45)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

A [1,5] sigmatropic hydrogen shift induced by high vibrational overtone excitation: the isomerization of 2-methylcyclopentadiene

1 - Laser Isotope Separation

1 - Laser Sources

100,000 Genomes Pilot on Rare-Disease Diagnosis in Health Care — Preliminary Report

(1338) - Perception vs. Reality: Reported and Objective Measures of Physical Activity in Children with Hypertrophic Cardiomyopathy (HCM)

2015 SPCTPD/ACC/AAP/AHA Training Guidelines for Pediatric Cardiology Fellowship Programs (Revision of the 2005 Training Guidelines for Pediatric Cardiology Fellowship Programs)

234O Maintenance olaparib for patients (pts) with newly diagnosed, advanced ovarian cancer (OC) and a BRCA mutation (BRCAm): 5-year (y) follow-up (f/u) from SOLO1

487 ARTISTRY-7: a phase 3, multicenter study of nemvaleukin alfa in combination with pembrolizumab versus chemotherapy in patients with platinum-resistant epithelial ovarian, fallopian tube, or primary peritoneal cancer (GOG-3063; ENGOT-OV68)

517O Overall survival (OS) at 7-year (y) follow-up (f/u) in patients (pts) with newly diagnosed advanced ovarian cancer (OC) and a BRCA mutation (BRCAm) who received maintenance olaparib in the SOLO1/GOG-3004 trial

811MO Maintenance olaparib for patients (pts) with newly diagnosed, advanced ovarian cancer (OC) and a BRCA mutation (BRCAm): 5-year (y) follow-up (f/u) from SOLO1

818P Veliparib with carboplatin and paclitaxel in frontline high-grade serous ovarian cancer (HGSOC): Efficacy and safety of paclitaxel weekly and every 3 weeks in the VELIA study

995PD - Time to second progression (PFS2) and second subsequent therapy (TSST) for patients (pts) with newly diagnosed, advanced ovarian cancer (OC) and a BRCA mutation (BRCAm) treated with maintenance (mt) olaparib (ola): Phase III SOLO1 trial

995PDTime to second progression (PFS2) and second subsequent therapy (TSST) for patients (pts) with newly diagnosed, advanced ovarian cancer (OC) and a BRCA mutation (BRCAm) treated with maintenance (mt) olaparib (ola): Phase III SOLO1 trial

996PD - Patient-centred outcomes with maintenance olaparib in newly diagnosed patients with advanced ovarian cancer (OC) and a BRCA mutation (BRCAm) in the phase III SOLO1 trial to support the clinical benefit of prolongation of progression-free survival (PFS)

996PDPatient-centred outcomes with maintenance olaparib in newly diagnosed patients with advanced ovarian cancer (OC) and a BRCA mutation (BRCAm) in the phase III SOLO1 trial to support the clinical benefit of prolongation of progression-free survival (PFS)

The Abdominal Trauma Index—A Critical Reassessment and Validation

Absolute yields of carbon monoxide, carbon dioxide, and formaldehyde from the reaction methylene(~X3B1) + oxygen by IR diode laser flash kinetic spectroscopy

Absolute yields of CO, CO2, and H2CO from the reaction CH2(X3B1) + O2 by IR diode laser flash kinetic spectroscopy

Absorption of fortification iron in bread

Abstract 2862: The balance of divergent IRE1α signaling regulates pancreatic neuroendocrine tumor growth

ACCF/ACR/AIUM/ASE/ASN/ICAVL/SCAI/SCCT/SIR/SVM/SVS 2012 Appropriate Use Criteria for Peripheral Vascular Ultrasound and Physiological Testing Part I: Arterial Ultrasound and Physiological Testing

Activation and cleaning of oxide surfaces by a cw CO 2 laser

Suchergebnisse filtern